Enmein, 13-deoxy-19-hydroxy-, (19R)-
CAS No. 16763-48-7
Enmein, 13-deoxy-19-hydroxy-, (19R)-( —— )
Catalog No. M29499 CAS No. 16763-48-7
Enmein, 13-deoxy-19-hydroxy-, (19R)- is an Enmein-?type diterpene derivative and can be used in the preparation of antitumor drugs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 264 | Get Quote |
|
| 5MG | 403 | Get Quote |
|
| 10MG | 592 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEnmein, 13-deoxy-19-hydroxy-, (19R)-
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnmein, 13-deoxy-19-hydroxy-, (19R)- is an Enmein-?type diterpene derivative and can be used in the preparation of antitumor drugs.
-
DescriptionEnmein, 13-deoxy-19-hydroxy-, (19R)- is an Enmein-?type diterpene derivative and can be used in the preparation of antitumor drugs.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16763-48-7
-
Formula Weight362.42
-
Molecular FormulaC20H26O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@]2([C@@]3([C@]4([C@]5([C@H](O)[C@@H](CC4)C(=C)C5=O)C(=O)O[C@]3(CCC2(C)C)[H])[H])CO1)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sibrotuzumab
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting Fibroblast Activating Protein (FAP) and is used in the study of colorectal cancer and non-small cell lung cancer.
-
Cys-CD36 (139-155)
CD36 Peptide P (139-155), Cys conjugated is a Cys labelled CD36 Peptide, and can inhibit the immunoadsorption of CD36 by OKM5.
-
Kras4B G12D-IN-1
Kras4B G12D-IN-1 is an anticancer agent that functions as an inhibitor of the Kras4B G12D protein. It effectively reduces the expression of Kras protein in mouse embryonic fibroblasts (MEFs) harboring the Kras4B G12D mutation.
Cart
sales@molnova.com